SELLAS Life Sciences Group, Inc. (SLS)
5.26
-0.02
(-0.38%)
USD |
NASDAQ |
Mar 06, 10:54
SELLAS Life Sciences Group Research and Development Expense (Annual) : 19.10M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| GT Biopharma, Inc. | 3.472M |
| Amicus Therapeutics, Inc. | 135.84M |
| Geron Corp. | 71.43M |
| Vanda Pharmaceuticals, Inc. | 109.27M |
| ADMA Biologics, Inc. | 4.762M |